ABBV Price Prediction Next Week
Technical Analysis: Based on the latest technical indicators, ABBV shows strong bullish momentum:
- RSI-14 at 77.28 indicates overbought conditions but still has room to run
- MACD is positive with bullish crossover (MACD 5.79, Signal 4.61)
- Price trading above all major moving averages (SMA 5,10,20,60,200)
- Stochastic RSI showing strong upward momentum
Price Target Analysis: Using Fibonacci projections and technical resistance levels:
- Support levels: $189.70 (Fib S1), $185.99 (Fib S2)
- Resistance levels: $201.70 (Fib R1), $205.41 (Fib R2)
- Current price: $202.38 (pre-market)
News Sentiment Impact: Recent positive catalysts:
- Strong Q4 2024 earnings with 6% sales growth
- Skyrizi and Rinvoq combined sales reached $17.7B in 2024, up 51% YoY
- Management raised 2027 sales outlook for Skyrizi and Rinvoq to over $31B
- DOJ defending Medicare price negotiations, reducing uncertainty
Price Prediction for Next Week: Based on technical setup and positive fundamentals:
- Base case (60% probability): $205-208 range
- Bullish case (30% probability): Break above $211.42 (Fib R3)
- Bearish case (10% probability): Pull back to $195-198 support zone
Trading Recommendation: BUY
- Entry point: Current pre-market price ($202.38)
- Stop loss: $198.50 (below 5-day SMA)
- First target: $205.41 (Fib R2)
- Second target: $211.42 (Fib R3)
The stock shows strong momentum with solid fundamentals and positive technical setup. The risk/reward ratio favors longs with defined risk below recent support levels.
ABBV Similar Chart Price Prediction
The price of ABBV is predicted to go up 4.06%, based on the high correlation periods with UL. The similarity of these two price pattern on the periods is 98.67%.
ABBV
UL
Up: 4.06%Similarity: 98.67%
ABBV Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030
Year
ABBV Price Forecast($)
Potential Return(%)
2025
181.340
0.070
2026
220.000
19.630
2027
250.000
35.940
2028
250.000
35.940
2029
250.000
35.940
2030
250.000
35.940
What is ABBV stock price prediction 2025 ?
What is ABBV stock price prediction 2026 ?
What is ABBV stock price prediction 2027 ?
What is ABBV stock price prediction 2028 ?
What is ABBV stock price prediction 2029 ?
What is ABBV stock price prediction 2030 ?
ABBV Revenue Forecast
ABBV EPS Forecast
ABBV FAQs
What is bull’s view on ABBV?
What is bear's view on ABBV?
What is ABBV revenue forecast for next quarter？
What is ABBV eps forecast for next quarter？
ABBV VS S&P500
AbbVie supports a strong dividend yield, which should act as valuation support, as the cash flows to support the dividend look secure over the next several years.
AbbVie's strong entrenchment in the aesthetics business (gained through the Allergan acquisition) sets up very long product cycles for several key assets like Botox based on strong brand power and physician entrenchment.
AbbVie's next generation immunology drugs targeting the IL23 and JAK pathways should help mitigate the competitive threats facing Humira over the next five years.
ABBV Analyst's Forecast
Mohit Bansal
Wells Fargo
Buy
2025-02-03
Price Target
$195 → $210
Upside
+9.99%
Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of $460. The firm sees limited upside for the shares in the near-term. Vertex lacks major catalysts this year and Wells does not believe the Alyftrek and suzetrigine launches are "needle movers" for the stock, the analyst tells investors in a research note. The firm favors shares of Gilead (GILD), AbbVie (ABBV), and Eli Lilly (LLY) to Vertex. Wells thinks Vertex may need to do more pipeline deals.
Gary Nachman
Raymond James
Buy
2025-02-03
Price Target
$218 → $220
Upside
+15.23%
Srikripa Devarakonda
Truist Securities
Strong Buy
2025-01-08
Price Target
$215 → $211
Upside
+18.66%
